(1) Yunnan Baiyao: It is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines and biological products. Its circulation market value ranks first in the industry, reaching 8265438+97 million yuan, with a price-earnings ratio of 24.28;
(2) Pien Tze Huang: the leader of traditional Chinese medicine, Pien Tze Huang's quarterly report 202 1 2 shows that the total operating income increased by 2.057% to1847 million yuan, and the net profit increased by 385.4% to 550 million yuan. The prescription of Pien Tze Huang, a leading figure in the field of traditional Chinese medicine, belongs to the top secret formula of the country and is one of the few drugs that allow the use of natural musk. The core products of the company are Pien Tze Huang series, including Pien Tze Huang, Pien Tze Huang capsules, compound Pien Tze Huang ointment and compound Pien Tze Huang buccal tablets. Actively create a strategic pattern of "one core and many products" in pharmaceutical manufacturing. Pien Tze Huang Cosmetics, a subsidiary, has many brands such as Pien Tze Huang and Empress.
(3) Baiyun Mountain: the leader of traditional Chinese medicine. According to the second quarter of 20021,the company's operating income increased by 19.26% to1608 million yuan, and its net profit increased by 50.75% to 875 million yuan. After years of painstaking efforts and accelerated development, the Group has gradually formed four business segments: Da Nan Medicine, Da Health, Da Commerce and Da Medical, and three new formats: e-commerce, capital finance and medical devices.
(4) Tongrentang: the leader of traditional Chinese medicine, Tongrentang's total operating income in the second quarter of 2002/kloc-0 increased by 22.84% year-on-year to 3.653 billion yuan, and its net profit increased by 2.6 1% year-on-year to 306 million yuan. The parent company has more than 500 product approval numbers, and produces more than 200 varieties all the year round, covering 28 product forms such as pills, powders, medicinal liquor, capsules, oral liquid and dropping pills, and has formed a series of cardiovascular and cerebrovascular diseases represented by Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Dahuoluo Pill. Gynecological series represented by Tongren Wuji Baifeng Pill and Bao Kun Pill, and alcoholic series represented by Guogong Liquor and Guci Xiaotong Liquid, etc. 12 varieties of different series.
(5) Neptune Biology: The company produces about 500 kinds of products, which are divided into four categories: chemical medicine, traditional Chinese medicine, health food and biological medicine, forming a complete product system dominated by anti-tumor products, covering cardiovascular system, respiratory system, digestive system, etc.1/categories (April 8, 20 13, the company
(6) Fengyuan Pharmaceutical Co., Ltd.: The company is the first high-tech enterprise in China to produce cilnidipine, a specific drug for treating hypertension. It has independent intellectual property rights of a number of national first-class and second-class new drug products and has passed the national double-high certification. Mainly engaged in biological drugs, traditional Chinese medicine, chemical synthetic drugs and their preparations.
(7) Dong 'e Ejiao: The company's main business is Chinese medicine industry, and it is the largest Ejiao manufacturer in China. The company's main business is Chinese medicine industry, and it is the largest Ejiao production enterprise in China.
(8) Livzon Group: Shenqi Fuzheng Injection is the exclusive variety of the company, which belongs to the protected variety of traditional Chinese medicine and is listed in the national medical insurance catalogue.